Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,352
Total Claims
$709K
Drug Cost
538
Beneficiaries
$1,318
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+23%
Cost per patient vs peers
$1,318 vs $1,068 avg
+25%
Brand preference vs peers
11.3% vs 9.0% avg
Brand vs Generic
Brand: 2,152 claims · $471K
Generic: 16,915 claims · $229K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 262 | $141K |
| Sacubitril/Valsartan | 67 | $41K |
| Rivaroxaban | 75 | $39K |
| Insulin Aspart Prot/Insuln Asp | 89 | $38K |
| Alogliptin Benzoate | 174 | $31K |
| Bimatoprost | 134 | $31K |
| Budesonide/Formoterol Fumarate | 104 | $24K |
| Sitagliptin Phosphate | 35 | $18K |
| Albuterol Sulfate | 363 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 161 | $14K |
| Insulin Aspart | 77 | $9,724 |
| Losartan Potassium | 595 | $9,275 |
| Ezetimibe | 134 | $9,068 |
| Levothyroxine Sodium | 231 | $9,006 |
| Esomeprazole Magnesium | 189 | $8,836 |
Prescribing Profile
Patient Profile
76
Avg Age
55%
Female
2.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data